The American Diabetes Association warns against the use of compounded versions of popular diabetes and weight loss drugs like Wegovy and Zepbound, citing concerns over safety, quality, and effectiveness. The organization urges healthcare professionals to adhere to approved formulations due to potential dosing errors and adverse events linked to compounded products. Amid ongoing shortages, the FDA has faced legal challenges regarding its enforcement of compounding regulations, complicating the landscape for these medications.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.